SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-01-24 14:05
Tx date 2024-01-22 		$DMAC
DiaMedica Therapeutics Inc. 		Masuoka, Lorianne
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+285,000 vol 		285,000
Filed 2024-01-24 13:32
Tx date 2024-01-22 		$DMAC
DiaMedica Therapeutics Inc. 		Masuoka, Lorianne
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-06-29 13:17
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Jacinto II, Richard
3 - 10% Security Holder of Issuer
Holder: NFS/FMTC Roth IRA FBO Richard Jacinto II (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		4,558,823
Filed 2023-06-29 13:15
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Jacinto II, Richard
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-06-29 13:14
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Jacinto II, Richard
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-06-28 11:45
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEqt Private AB (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$4,999,999
+1,470,588 vol
$3.40 each 		4,326,435
Filed 2023-06-28 11:42
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		TomEqt Private AB
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$4,999,999
+1,470,588 vol
$3.40 each 		4,326,435
Filed 2023-06-28 11:41
Tx date 2022-12-02 		$DMAC
DiaMedica Therapeutics Inc. 		TomEqt Private AB
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,855,847
Filed 2023-06-28 11:40
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		von Koch, Nina
6 - Director or Senior Officer of 10% Security Holder
Holder: TomEqt Private AB (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$4,999,999
+1,470,588 vol
$3.40 each 		4,326,435
Filed 2023-06-28 11:39
Tx date 2022-12-02 		$DMAC
DiaMedica Therapeutics Inc. 		von Koch, Nina
6 - Director or Senior Officer of 10% Security Holder
Holder: TomEqt Private AB (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,855,847
Filed 2023-06-28 11:31
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Trill AB
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$4,999,999
+1,470,588 vol
$3.40 each 		4,021,608
Filed 2023-06-28 11:31
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Trill AB
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,551,020
Filed 2023-06-28 11:27
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Gustafsson, Jennie
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$4,999,999
+1,470,588 vol
$3.40 each 		4,021,608
Filed 2023-06-28 11:27
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Gustafsson, Jennie
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,551,020
Filed 2023-06-28 11:24
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$4,999,999
+1,470,588 vol
$3.40 each 		4,021,608
Filed 2023-06-28 11:24
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,551,020
Filed 2023-06-28 09:38
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Colleen, Per
6 - Director or Senior Officer of 10% Security Holder
Holder: TomEqt Private AB (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$4,999,999
+1,470,588 vol
$3.40 each 		4,326,435
Filed 2023-06-28 09:36
Tx date 2022-12-12 		$DMAC
DiaMedica Therapeutics Inc. 		Colleen, Per
6 - Director or Senior Officer of 10% Security Holder
Holder: TomEqt Private AB (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,855,847
Filed 2023-06-26 12:47
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
-15,000 vol 		97,748
Filed 2023-06-26 12:46
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$254,150
+65,000 vol
$3.91 each 		112,748
Filed 2023-06-26 12:44
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$39,100
+10,000 vol
$3.91 each 		34,330
Filed 2023-06-26 12:43
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$39,100
+10,000 vol
$3.91 each
Filed 2023-06-26 12:41
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$39,100
+10,000 vol
$3.91 each
Filed 2023-06-26 12:41
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$150,003
+38,364 vol
$3.91 each 		507,114
Filed 2023-06-26 12:39
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$49,997
+12,787 vol
$3.91 each 		46,842
Filed 2023-06-26 12:38
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Semba, Charles
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$49,997
+12,787 vol
$3.91 each 		12,787
Filed 2023-06-26 12:38
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Semba, Charles
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-06-26 12:37
Tx date 2023-06-23 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$149,999
+38,363 vol
$3.91 each 		106,453
Filed 2023-06-09 13:19
Tx date 2023-05-30 		$DMAC
DiaMedica Therapeutics Inc. 		Kuntz, Richard
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		32,320
Filed 2023-06-05 17:03
Tx date 2023-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Daves, Julie VanOrsdel
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+54,000 vol 		194,000
Filed 2023-06-05 17:02
Tx date 2023-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Cundari, Dominic
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+27,000 vol 		192,000
Filed 2023-06-05 17:00
Tx date 2023-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Gruis, Kirsten
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+67,000 vol 		227,000
Filed 2023-06-05 16:59
Tx date 2023-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+67,000 vol 		312,000
Filed 2023-06-05 16:57
Tx date 2023-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+181,000 vol 		882,000
Filed 2023-06-05 16:55
Tx date 2023-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Semba, Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+16,968 vol 		35,754
Filed 2023-06-05 16:53
Tx date 2023-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+22,355 vol 		130,925
Filed 2023-06-05 16:50
Tx date 2023-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Lewis, Tanya
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+7,493 vol 		33,936
Filed 2023-06-05 16:34
Tx date 2023-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+16,968 vol 		83,867
Filed 2023-04-13 14:16
Tx date 2023-04-10 		$DMAC
DiaMedica Therapeutics Inc. 		Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+140,000 vol 		140,000
Filed 2023-04-12 19:46
Tx date 2023-04-10 		$DMAC
DiaMedica Therapeutics Inc. 		Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		468,750
Filed 2023-04-12 19:45
Tx date 2023-04-10 		$DMAC
DiaMedica Therapeutics Inc. 		Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-04-12 19:41
Tx date 2023-04-10 		$DMAC
DiaMedica Therapeutics Inc. 		Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-03-09 20:38
Tx date 2023-03-01 		$DMAC
DiaMedica Therapeutics Inc. 		Lewis, Tanya
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+26,443 vol 		26,443
Filed 2023-03-09 20:34
Tx date 2023-03-01 		$DMAC
DiaMedica Therapeutics Inc. 		Lewis, Tanya
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-03-09 17:42
Tx date 2023-03-01 		$DMAC
DiaMedica Therapeutics Inc. 		Lewis, Tanya
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		26,443
Filed 2023-03-09 17:42
Tx date 2023-03-01 		$DMAC
DiaMedica Therapeutics Inc. 		Lewis, Tanya
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-12-07 16:33
Tx date 2022-12-02 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEqt Private AB (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership
+2,855,847 vol 		2,855,847
Filed 2022-12-07 16:32
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEqt Private AB (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-12-07 16:32
Tx date 2022-12-02 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership
-2,855,847 vol 		0
Filed 2022-09-14 19:06
Tx date 2022-09-13 		$DMAC
DiaMedica Therapeutics Inc. 		Daves, Julie VanOrsdel
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		140,000
Filed 2022-07-21 16:58
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$8,739
+6,450 vol
$1.35 each 		2,855,847
Filed 2022-07-21 16:58
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$10,845
+8,034 vol
$1.35 each 		2,849,397
Filed 2022-07-21 16:57
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$259.58
+193 vol
$1.34 each 		2,841,363
Filed 2022-07-21 16:57
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$9,784
+7,302 vol
$1.34 each 		2,841,170
Filed 2022-07-21 16:56
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$83,408
+62,478 vol
$1.33 each 		2,833,868
Filed 2022-07-21 16:56
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$6,007
+4,517 vol
$1.33 each 		2,771,390
Filed 2022-07-21 16:55
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$55,339
+41,766 vol
$1.32 each 		2,766,873
Filed 2022-07-21 16:55
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$2,815
+2,129 vol
$1.32 each 		2,725,107
Filed 2022-07-21 16:54
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$49,349
+37,386 vol
$1.32 each 		2,722,978
Filed 2022-07-21 16:54
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$57,487
+43,717 vol
$1.31 each 		2,685,592
Filed 2022-07-21 16:53
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$4,058
+3,098 vol
$1.31 each 		2,641,875
Filed 2022-07-21 16:53
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$10,484
+8,034 vol
$1.30 each 		2,638,777
Filed 2022-07-21 16:52
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$629.11
+483 vol
$1.30 each 		2,630,743
Filed 2022-07-21 16:52
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$250.90
+193 vol
$1.30 each 		2,630,260
Filed 2022-07-21 16:51
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$32,962
+25,454 vol
$1.29 each 		2,630,067
Filed 2022-07-21 16:51
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$4,215
+3,268 vol
$1.29 each 		2,604,613
Filed 2022-07-21 16:50
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$2,016
+1,569 vol
$1.28 each 		2,601,345
Filed 2022-07-21 16:50
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$122.88
+96 vol
$1.28 each 		2,599,776
Filed 2022-07-21 16:49
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$617.10
+484 vol
$1.27 each 		2,599,680
Filed 2022-07-21 16:49
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$4,497
+3,541 vol
$1.27 each 		2,599,196
Filed 2022-07-21 16:48
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$1,588
+1,258 vol
$1.26 each 		2,595,655
Filed 2022-07-21 16:47
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$18,178
+14,370 vol
$1.26 each 		2,594,397
Filed 2022-07-21 16:47
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$33,828
+26,848 vol
$1.26 each 		2,580,027
Filed 2022-07-21 16:46
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$2,587
+2,062 vol
$1.25 each 		2,553,179
Filed 2022-07-21 16:46
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$121.25
+97 vol
$1.25 each 		2,551,117
Filed 2022-07-21 16:45
Tx date 2022-07-08 		$DMAC
DiaMedica Therapeutics Inc. 		Von Koch, Nils Thomas
3 - 10% Security Holder of Issuer
Holder: TomEnterprise AB (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,551,020
Filed 2022-02-14 13:38
Tx date 2022-01-03 		$DMAC
DiaMedica Therapeutics Inc. 		Burroughs, Amy Louise
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+11,182 vol 		11,182
Filed 2022-02-14 13:37
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Burroughs, Amy Louise
4 - Director of Issuer
Direct Ownership
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-14 13:36
Tx date 2021-08-16 		$DMAC
DiaMedica Therapeutics Inc. 		Burroughs, Amy Louise
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$141,592
+44,950 vol
$3.15 each 		44,950
Filed 2022-02-14 13:35
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Burroughs, Amy Louise
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-10 16:36
Tx date 2022-01-03 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+15,026 vol 		112,753
Filed 2022-02-10 16:35
Tx date 2022-02-10 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Options
99 - Correction of information
-585,750 vol 		66,899
Filed 2022-02-10 16:34
Tx date 2021-10-06 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-1,250 vol 		652,649
Filed 2022-02-10 16:33
Tx date 2016-04-13 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-1,250 vol 		358,250
Filed 2022-02-10 16:32
Tx date 2016-04-10 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-5,500 vol 		384,500
Filed 2022-02-10 16:29
Tx date 2022-02-10 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Deferred Share Units
99 - Correction of information
-78,778 vol 		33,975
Filed 2022-02-10 16:27
Tx date 2022-01-03 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+15,026 vol
Filed 2022-02-09 18:41
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights 		$57,766
+7,019 vol
$8.23 each 		97,727
Filed 2022-02-09 18:38
Tx date 2020-03-29 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-204,082 vol 		0
Filed 2022-02-09 18:31
Tx date 2017-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Stephen Giuffre (Indirect Ownership)
Warrants
55 - Expiration of warrants
-1,350 vol 		0
Filed 2022-02-09 18:28
Tx date 2017-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Martin Giuffre (Indirect Ownership)
Warrants
55 - Expiration of warrants
-1,150 vol 		0
Filed 2022-02-09 18:27
Tx date 2017-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Christina Giuffre (Indirect Ownership)
Warrants
55 - Expiration of warrants
-1,150 vol 		0
Filed 2022-02-09 18:25
Tx date 2017-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Anthony Giuffre (Indirect Ownership)
Warrants
55 - Expiration of warrants
-1,350 vol 		0
Filed 2022-02-09 18:24
Tx date 2017-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Adrianna Giuffre (Indirect Ownership)
Warrants
55 - Expiration of warrants
-1,150 vol 		0
Filed 2022-02-09 18:23
Tx date 2017-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: 424822 Alberta Ltd. (Indirect Ownership)
Warrants
55 - Expiration of warrants
-20,800 vol 		0
Filed 2022-02-09 18:18
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Common Shares
99 - Correction of information
-693,466 vol 		47,748
Filed 2022-02-09 18:15
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Stephen Giuffre TFSA (Indirect Ownership)
Common Shares
99 - Correction of information
-104,500 vol 		5,500
Filed 2022-02-09 18:13
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Stephen Giuffre (Indirect Ownership)
Common Shares
99 - Correction of information
-73,910 vol 		3,890
Filed 2022-02-09 18:11
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Michael Giuffre TFSA (Indirect Ownership)
Common Shares
99 - Correction of information
-103,170 vol 		5,430
Filed 2022-02-09 18:10
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Michael Giuffre (RRSP) (Indirect Ownership)
Common Shares
99 - Correction of information
-477,185 vol 		25,115
Filed 2022-02-09 18:08
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Michael Giuffre (Indirect Ownership)
Common Shares
99 - Correction of information
-63,935 vol 		3,365
Filed 2022-02-09 18:06
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Martin Giuffre TFSA (Indirect Ownership)
Common Shares
99 - Correction of information
-104,880 vol 		5,520
Filed 2022-02-09 18:04
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Martin Giuffre (Indirect Ownership)
Common Shares
99 - Correction of information
-71,060 vol 		3,740
Filed 2022-02-09 18:00
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Heather Giuffre (RRSP) (Indirect Ownership)
Common Shares
99 - Correction of information
-296,685 vol 		15,615
Filed 2022-02-09 17:59
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Heather Giuffre (Indirect Ownership)
Common Shares
99 - Correction of information
-475 vol 		25
Filed 2022-02-09 17:58
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Heather Giuffre TFSA (Indirect Ownership)
Common Shares
99 - Correction of information
-103,170 vol 		5,430
Filed 2022-02-09 17:55
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Christina Giuffre TFSA (Indirect Ownership)
Common Shares
99 - Correction of information
-162,640 vol 		8,560
Filed 2022-02-09 17:53
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Christina Giuffre (Indirect Ownership)
Common Shares
99 - Correction of information
-132,905 vol 		6,995
Filed 2022-02-09 17:51
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Anthony Giuffre TFSA (Indirect Ownership)
Common Shares
99 - Correction of information
-94,050 vol 		4,950
Filed 2022-02-09 17:49
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Anthony Giuffre (Indirect Ownership)
Common Shares
99 - Correction of information
-74,100 vol 		3,900
Filed 2022-02-09 17:47
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Adrianna Giuffre TFSA (Indirect Ownership)
Common Shares
99 - Correction of information
-98,895 vol 		5,205
Filed 2022-02-09 17:45
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: Adrianna Giuffre (Indirect Ownership)
Common Shares
99 - Correction of information
-73,815 vol 		3,885
Filed 2022-02-09 17:43
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Holder: 424822 Alberta Ltd. (Indirect Ownership)
Common Shares
99 - Correction of information
-98,135 vol 		5,165
Filed 2022-02-09 16:51
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
99 - Correction of information
-4,104,000 vol 		701,000
Filed 2022-02-09 16:49
Tx date 2021-07-28 		$DMAC
DiaMedica Therapeutics Inc. 		Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
+175,000 vol 		4,815,000
Filed 2022-02-09 16:46
Tx date 2021-10-06 		$DMAC
DiaMedica Therapeutics Inc. 		Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-10,000 vol 		4,805,000
Filed 2022-02-09 16:43
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
99 - Correction of information
-438,045 vol 		34,055
Filed 2022-02-09 16:40
Tx date 2021-08-16 		$DMAC
DiaMedica Therapeutics Inc. 		Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$15,700
+5,000 vol
$3.14 each 		472,100
Filed 2022-02-09 16:38
Tx date 2020-03-29 		$DMAC
DiaMedica Therapeutics Inc. 		Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-41,000 vol 		0
Filed 2022-02-09 16:36
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Units Deferred Share Units
99 - Correction of information
-33,236 vol 		1,749
Filed 2022-02-09 14:47
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Common Shares
99 - Correction of information
-190,000 vol 		68,090
Filed 2022-02-09 14:45
Tx date 2021-08-16 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$49,065
+15,000 vol
$3.27 each 		258,090
Filed 2022-02-09 14:44
Tx date 2020-04-12 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$53,700
+10,000 vol
$5.37 each 		243,090
Filed 2022-02-09 14:41
Tx date 2022-01-03 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights 		$85,067
+23,762 vol
$3.58 each 		195,416
Filed 2022-02-09 14:36
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Deferred Share Units
99 - Correction of information
-144,179 vol 		51,237
Filed 2022-02-09 14:33
Tx date 2022-01-03 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+23,762 vol
Filed 2022-02-09 14:29
Tx date 2022-02-09 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Options
99 - Correction of information
-1,117,500 vol 		108,570
Filed 2022-02-09 14:07
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights 		$79,987
+9,719 vol
$8.23 each 		171,654
Filed 2021-01-05 19:40
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately 		$79,987
+9,719 vol
$8.23 each
Filed 2021-01-05 19:36
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately 		$61,239
+7,441 vol
$8.23 each
Filed 2022-02-08 19:29
Tx date 2022-02-08 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
99 - Correction of information
-475,000 vol 		60,649
Filed 2022-02-08 19:26
Tx date 2022-02-08 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
99 - Correction of information
-73,150 vol 		36,259
Filed 2022-02-08 19:23
Tx date 2022-01-03 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights 		$60,047
+16,773 vol
$3.58 each 		109,409
Filed 2022-02-08 19:15
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights 		$62,004
+7,534 vol
$8.23 each 		92,636
Filed 2022-02-08 19:13
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately 		$62,004
+7,534 vol
$8.23 each
Filed 2022-02-08 19:08
Tx date 2021-07-28 		$DMAC
DiaMedica Therapeutics Inc. 		Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+60,000 vol 		1,199,750
Filed 2022-02-08 19:07
Tx date 2022-02-08 		$DMAC
DiaMedica Therapeutics Inc. 		Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
99 - Correction of information
-954,750 vol 		245,000
Filed 2022-02-08 19:05
Tx date 2021-07-28 		$DMAC
DiaMedica Therapeutics Inc. 		Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+60,000 vol
Filed 2022-02-08 19:00
Tx date 2022-02-08 		$DMAC
DiaMedica Therapeutics Inc. 		Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
99 - Correction of information
-75,520 vol 		24,330
Filed 2022-02-08 18:59
Tx date 2021-08-16 		$DMAC
DiaMedica Therapeutics Inc. 		Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$31,463
+10,000 vol
$3.15 each 		99,850
Filed 2022-02-08 18:54
Tx date 2021-08-16 		$DMAC
DiaMedica Therapeutics Inc. 		Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$31,463
+10,000 vol
$3.15 each
Filed 2022-02-08 18:48
Tx date 2021-08-16 		$DMAC
DiaMedica Therapeutics Inc. 		Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$31,463
+10,000 vol
$3.15 each
Filed 2022-02-08 17:59
Tx date 2021-09-15 		$DMAC
DiaMedica Therapeutics Inc. 		Alcorn, Harry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$56,959
+15,000 vol
$3.80 each 		43,981
Filed 2022-02-08 17:58
Tx date 2021-08-16 		$DMAC
DiaMedica Therapeutics Inc. 		Alcorn, Harry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$64,069
+20,721 vol
$3.09 each 		28,981
Filed 2022-02-08 17:57
Tx date 2021-07-28 		$DMAC
DiaMedica Therapeutics Inc. 		Alcorn, Harry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$300,000
+60,000 vol
$5.00 each 		245,000
Filed 2022-02-08 17:55
Tx date 2018-08-23 		$DMAC
DiaMedica Therapeutics Inc. 		Alcorn, Harry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,000
+25,000 vol
$0.52 each 		25,000
Filed 2021-01-05 19:38
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately 		$63,741
+7,745 vol
$8.23 each
Filed 2018-08-24 13:57
Tx date 2018-08-23 		$DMAC
DiaMedica Therapeutics Inc. 		Alcorn, Harry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$260,000
+500,000 vol
$0.52 each
Filed 2022-02-07 17:57
Tx date 2022-01-03 		$DMAC
DiaMedica Therapeutics Inc. 		Gruis, Kirsten
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+160,000 vol 		160,000
Filed 2022-02-07 17:55
Tx date 2022-01-03 		$DMAC
DiaMedica Therapeutics Inc. 		Gruis, Kirsten
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-07 17:52
Tx date 2022-02-01 		$DMAC
DiaMedica Therapeutics Inc. 		Cundari, Dominic
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		165,000
Filed 2022-02-07 17:51
Tx date 2022-02-01 		$DMAC
DiaMedica Therapeutics Inc. 		Cundari, Dominic
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+125,000 vol 		125,000
Filed 2022-02-07 17:44
Tx date 2022-02-01 		$DMAC
DiaMedica Therapeutics Inc. 		Cundari, Dominic
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-07 17:43
Tx date 2022-02-01 		$DMAC
DiaMedica Therapeutics Inc. 		Cundari, Dominic
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,800
Filed 2021-07-23 20:51
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,190
+9,393 vol
$3.64 each 		535,649
Filed 2021-07-23 20:49
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$47,866
+13,150 vol
$3.64 each 		1,226,070
Filed 2021-07-23 20:48
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,190
+9,393 vol
$3.64 each 		660,649
Filed 2021-07-23 20:46
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Semba, Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$68,381
+18,786 vol
$3.64 each 		18,786
Filed 2021-07-23 20:45
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Semba, Charles
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-07-23 11:55
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Burroughs, Amy Louise
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$68,381
+18,786 vol
$3.64 each 		18,786
Filed 2021-07-23 11:53
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Burroughs, Amy Louise
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-07-20 17:55
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$47,866
+13,150 vol
$3.64 each
Filed 2021-07-20 17:52
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,190
+9,393 vol
$3.64 each
Filed 2021-07-20 17:49
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,190
+9,393 vol
$3.64 each
Filed 2021-07-20 17:55
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$47,866
+13,150 vol
$3.64 each 		1,226,070
Filed 2021-07-20 17:52
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,190
+9,393 vol
$3.64 each 		660,649
Filed 2021-07-20 17:49
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,190
+9,393 vol
$3.64 each 		535,649
Filed 2021-01-05 19:40
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately 		$79,987
+9,719 vol
$8.23 each 		171,654
Filed 2021-01-05 19:38
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately 		$63,741
+7,745 vol
$8.23 each 		92,847
Filed 2021-01-05 19:36
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately 		$61,239
+7,441 vol
$8.23 each 		98,149
Filed 2020-06-02 18:19
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Gilman, Sydney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+17,500 vol 		67,500
Filed 2020-06-02 18:18
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+35,000 vol 		1,139,750
Filed 2020-06-02 18:16
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Alcorn, Harry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+35,000 vol 		660,000
Filed 2020-06-02 18:13
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+56,000 vol 		4,640,000
Filed 2020-06-02 18:00
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+19,220 vol 		1,212,920
Filed 2020-06-02 17:59
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+10,168 vol 		161,935
Filed 2020-06-02 17:58
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+13,306 vol 		526,256
Filed 2020-06-02 17:57
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+8,102 vol 		85,102
Filed 2020-06-02 17:55
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+7,784 vol 		90,708
Filed 2020-06-02 17:48
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+13,306 vol 		651,256
Filed 2020-06-02 17:47
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
Deferred Share Units
46 - Compensation for services
+7,784 vol